COYO-GMBH
20.7.2021 16:28:52 CEST | Business Wire | Press release
COYO, the leading social intranet and employee communications platform, lands a coup with the acquisition of Paris-based people analytics platform Jubiwee. For the past 5 years Jubiwee has been doubling its operations and customer-base yearly. Over 40 French blue-chip companies use Jubiwee to assess staff motivation or to support transformation projects. In joining forces with Jubiwee, COYO accelerates its internationalization outside the DACH region and adds a critical toolkit to its digital workplace proposition.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005881/en/
Since the virus fast-tracked remote work, countless businesses have learned that their operational effectiveness in remote scenarios was heavily dependent on employee engagement. With Jubiwee's engagement analytics tools and their own communications and intranet platform, COYO now brings a complete employee engagement offering to the market. Customers will be enabled to address the limitations of remote work and make it more successful for employers and employees alike.
To ensure continuity and stability both company- and product-wise, Thibaud Martin, co-founder of Jubiwee, will join the COYO management team. Jubiwee’s office in Paris will become COYO’s French head office. Jubiwee customers have already been informed that their product of choice will be continued and even enhanced.
With the ambition to build ‘sexy and engaging business software’, Hamburg-based tech entrepreneur Jan Marius Marquardt founded COYO in 2010. The current platform is a modern social intranet and employee app that empowers organizations to drive employee engagement and improve workplace culture. The platform has over 400 customers, serving more than 1 million end-users. Jan Marius Marquardt, founder and CEO of COYO, says: “I am beyond happy about joining forces with Jubiwee: It feels like the right step, pushing the company and product to the next level and accelerate our expansion to France, one of our priority markets. Beyond cool technology there is no better way to start building up a French presence than by teaming up with a French team that has already proven successful and shares our values. This addition is a next big step towards becoming the most widely adopted employee communications platform in the world.”
Both companies have European DNA, share the same culture and vision and are very product-focused: UX and UI are critical, while user adoption is above-market. Jubiwee’s tech and UX-centered product resonates strongly with COYO’s product philosophy. Jan Marius Marquardt explains: “A capable engagement analytics solution is instrumental in a truly 360° employee communications offering and will bring a lot of value to customers. The merger thus presents an excellent opportunity for both current German and French customers.”
Jubiwee was founded in 2016 by Thibaud Martin, Victor Mustar, and Antoine Bellion. The company offers a new generation engagement analytics platform with a user-centric approach to improve employee experience, reduce turnover and improve retention. Thibaud Martin, co-founder, and CEO of Jubiwee, explains: “The people analytics and overall employee engagement market has grown tremendously in recent months, partly due to the COVID-crisis. Also, customers have grown more mature and demanding. To capitalize on this shift, we decided to partner with a strong, renowned, and ambitious company that shares the same values: COYO. Joining forces with COYO is the best way to build a more comprehensive offer and accelerate at this crucial time.”
Both solutions will be continued in their current form and developed according to their respective roadmaps. Short-term ambitions include continuing Jubiwee’s growth in France, cross-selling respective solutions to existing customers and prospects as well as introducing the COYO offer in France. Mid and long-term ambitions include integrating both solutions to offer a complete employee engagement suite, enabling companies to communicate, and take the pulse of their coworkers in a modern, efficient and seamless way. Overall, the companies’ solutions are complementary and together present a strong offering, both in terms of depth and breadth. By adding two very competent best-of-breed solutions, COYO and Jubiwee are creating one extremely compelling suite.
More information is available at www.coyoapp.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210720005881/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom